SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from MDxHealth SA (MDXH) — Feb 12, 2026

MDxHealth SA
Date: Feb. 12, 2026 · CIK: 0001872529 · Accession: 0001213900-26-015510

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-292463

Date
February 12, 2026
Author
/s/ Joseph Sollee
Form
CORRESP
Company
MDxHealth SA

Letter

Re: MDxHealth SA

MDxHealth SA

Zone Industrielle des Hauts-Sarts 4040 Herstal, Belgium

February 12, 2026

Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549

Attention: Margaret Sawicki

Registration Statement on Form F-3 (File No. 333-292463)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), registrant MDxHealth SA (the "Registrant") hereby respectfully requests that the above-referenced Registration Statement on Form F-3 be declared effective at 4:00 p.m., Eastern Time, on Tuesday, February 17, 2026, or as soon thereafter as is practicable or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission.

Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted.

We understand that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the Securities Act as they relate to the issuance of the securities covered by the Registration Statement.

Sincerely,
/s/ Joseph Sollee

Show Raw Text
CORRESP
 1
 filename1.htm

 MDxHealth SA

 Zone Industrielle des Hauts-Sarts
4040 Herstal, Belgium

 February 12, 2026

 Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

 Attention: Margaret Sawicki

 Re: MDxHealth SA

 Registration Statement on Form F-3 (File No. 333-292463)

 Ladies and Gentlemen:

 Pursuant to Rule 461 promulgated under the Securities Act of 1933,
as amended (the "Securities Act"), registrant MDxHealth SA (the "Registrant") hereby respectfully requests that
the above-referenced Registration Statement on Form F-3 be declared effective at 4:00 p.m., Eastern Time, on Tuesday, February 17, 2026,
or as soon thereafter as is practicable or at such later time as the Registrant or its counsel may orally request via telephone call to
the staff of the Commission.

 Please direct any questions regarding this request to Mark Busch of
K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has
been granted.

 We understand that the staff of the United States Securities and Exchange
Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the Securities
Act as they relate to the issuance of the securities covered by the Registration Statement.

 Sincerely,

 /s/ Joseph Sollee

 Joseph Sollee

 EVP Corporate Development and General Counsel